Search Results for "Cvs Minute Clinic Shingles Vaccine"

09:22 EST 29th January 2015 | BioPortfolio

Matching Channels


Varicella zoster virus (VZV) is one of eight herpes viruses known to infect humans (and other vertebrates). Varicella-zoster virus is known by many names, including: chickenpox virus, varicella viru...

HPV vaccine

Smallpox Vaccine MVA

Haemophilus b Vaccine GSK

Rotavirus Vaccine GSK

Matching News

GSK shingles vaccine on form

GlaxoSmithKline will be celebrating following the successful Phase III study of its shingles vaccine HZ/su that has met its primary endpoint. HZ/su reduced the risk of shingles by 97.2% in adults aged...

Shingles vaccine remains effective after chemotherapy

The herpes zoster vaccine continues to be effective in protecting older adults against shingles, even after they undergo chemotherapy, according to a study. Patients who were previously vaccinated wit...

New GSK shingles vaccine may challenge Merck after strong test data

LONDON (Reuters) - An experimental shingles vaccine from GlaxoSmithKline has produced impressive results in a late-stage study, giving the group's expanding vaccine unit a potential $1 billion boost. ...

GSK Shingles Vaccine Hits Goal in Major Study

GSK announced that a pivotal phase 3 study to assess the efficacy of HZ/su, an investigational vaccine for the prevention of shingles, has met its primary endpoint. Analysis of the primary endpoint s...

GlaxoSmithKline shingles vaccine hits goal in major study

LONDON, Dec 18 (Reuters) - An experimental vaccine against shingles from GlaxoSmithKline met its goal in a late-stage study, in a boost for the company's vaccine unit, which is expanding part of its o...

Shingles Vaccine Still Effective After Chemotherapy

FRIDAY, Aug. 8, 2014 (HealthDay News) -- The shingles vaccine remains effective in older people after they've had chemotherapy, a new study finds. "The zoster vaccine has been shown to be safe and ef...

BRIEF-GSK says shingles vaccine meets primary endpoint in late-stage trial

* Pivotal phase III study to assess efficacy of HZ/su, an investigational vaccine for prevention of shingles, has met its primary endpoint

GSK, Agenus shingles vaccine meets primary endpoint

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) said its HZ/su herpes zoster vaccine (GSK1437173A) met the primary endpoint of reducing the risk of shingles by 97.2% in people aged 50 and older vs. placebo in...

Matching PubMed Articles

Shingles vaccination: background and advice for community nurses.

Shingles (or zoster) is a reactivation of an existing varicella-zoster virus (VZV) infection. During the initial infection, VZV causes a systemic disease known as varicella or chickenpox, and this ini...

Impact of pharmacist integration in a pediatric primary care clinic on vaccination errors: A retrospective review.

OBJECTIVE To measure the impact of ambulatory clinical pharmacist integration in a pediatric primary care clinic on vaccination error rates and to evaluate missed opportunities. METHODS A retrospecti...

A179: improving pneumococcal vaccination rate in the pediatric rheumatology clinic.

This quality improvement project was conducted to increase pneumococcal vaccination rates in eligible Pediatric Rheumatology Clinic patients. Streptococcus pneumoniae is a leading cause of bacteremia,...

Parent perceptions important for HPV vaccine initiation among low income adolescent girls.

The study aims were to assess the influence of provider recommendations on parental vaccine perceptions and identify the most potent parent vaccine perceptions for HPV vaccine series initiation consid...

Use of a Pharmacy Protocol to Convert Standard Rituximab Infusions to Rapid Infusion Shortens Outpatient Infusion Clinic Visits.

To evaluate the impact of a pharmacy protocol that converts standard rituximab infusions to a rapid 90-minute infusion on the duration of outpatient infusion center clinic visits.

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement